$VTAK Catheter Precision, Inc. (NYSE American:VTAK
Post# of 107123
(Total Views: 214)
Posted On: 03/14/2024 8:36:13 AM
$VTAK Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
https://www.accesswire.com/842864/catheter-pr...o-in-qatar
FORT MILL, SC / ACCESSWIRE / March 14, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on innovative electrophysiology products, announced that VIVO was used in five procedures for the first time in Qatar at Hamad Medical Corporation Heart Hospital in Doha. Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals - nine specialist hospitals and three community hospitals.
"VIVO was recently used for five patients at Doha Heart Hospital in Qatar.", said David Jenkins, CEO of Catheter Precision. He continued, "The physicians were impressed with the accuracy of VIVO and we look forward to expanding our footprint in the middle east and continuing to show the benefits of VIVO in new territories."
https://www.accesswire.com/842864/catheter-pr...o-in-qatar
FORT MILL, SC / ACCESSWIRE / March 14, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on innovative electrophysiology products, announced that VIVO was used in five procedures for the first time in Qatar at Hamad Medical Corporation Heart Hospital in Doha. Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals - nine specialist hospitals and three community hospitals. "VIVO was recently used for five patients at Doha Heart Hospital in Qatar.", said David Jenkins, CEO of Catheter Precision. He continued, "The physicians were impressed with the accuracy of VIVO and we look forward to expanding our footprint in the middle east and continuing to show the benefits of VIVO in new territories."
(0)
(0)